{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:33:50Z","timestamp":1787762030512,"version":"build-2784847793"},"reference-count":57,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus behind the coronavirus disease 2019 (COVID-19) pandemic, is a type of RNA virus that is nonsegmented. Cardiovascular diseases (CVDs) increase the mortality risk of patients. In this review article, we overview the existing evidence regarding the potential mechanisms of myocardial damage in coronavirus disease 2019 (COVID-19) patients. Having a comprehensive knowledge of the cardiovascular damage caused by SARS-CoV-2 and its underlying mechanisms is essential for providing prompt and efficient treatment, ultimately leading to a reduction in mortality rates. Severe COVID-19 causes acute respiratory distress syndrome and shock in patients. In addition, awareness regarding COVID-19 cardiovascular manifestations has increased, including the adverse impact on prognosis with cardiovascular involvement. Angiotensin-converting enzyme 2 receptor may play a role in acute myocardial injury caused by SARS-CoV-2 infection. COVID-19 patients experiencing heart failure may have their condition exacerbated by various contributing factors and mechanisms. Increased oxygen demand, myocarditis, stress cardiomyopathy, elevated pulmonary pressures, and venous thrombosis are potential health issues. The combination of these factors may lead to COVID-19-related cardiogenic shock, resulting in acute systolic heart failure. Extracorporeal membrane oxygenation (ECMO) and left ventricular assist devices (LVADs) are treatment options when inotropic support fails for effective circulatory support. To ensure effective COVID-19-related cardiovascular disease (CVD) surveillance, it is crucial to closely monitor the future host adaptation, viral evolution, and transmissibility of SARS-CoV-2, given the virus\u2019s pandemic potential.<\/jats:p>","DOI":"10.4103\/tcmj.tcmj_219_22","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T04:00:39Z","timestamp":1686628839000},"page":"213-220","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Coronavirus disease 2019 and cardiovascular disease"],"prefix":"10.4103","volume":"35","author":[{"given":"Jenn-Yeu","family":"Song","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Surgery, Department of Surgery, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei, Taiwan"},{"name":"Department of Biomedical Sciences and Engineering, National Central University, Taoyuan, Taiwan"},{"name":"School of Medicine, Tzu Chi University, Hualien, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-You","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Medicine, Tzu Chi University, Hualien, Taiwan"},{"name":"Department of Anesthesiology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chiung","family":"Hsu","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Engineering, National Central University, Taoyuan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Men-Tzung","family":"Lo","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Engineering, National Central University, Taoyuan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Engineering, National Central University, Taoyuan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ta-Chung","family":"Shen","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Surgery, Department of Surgery, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Tser","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Taoyuan Armed Forces General Hospital Hsinchu Branch, Hsinchu, Taiwan"},{"name":"Department of Pediatrics, Taoyuan Armed Forces General Hospital, Taoyuan, Taiwan"},{"name":"Department of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Cheng","family":"Lu","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,6,13]]},"reference":[{"key":"R1-20240828","doi-asserted-by":"crossref","first-page":"114114","DOI":"10.1016\/j.bcp.2020.114114","article-title":"SARS-CoV-2 and cardiovascular complications:From molecular mechanisms to pharmaceutical management","volume":"178","author":"Wu","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"R2-20240828","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","article-title":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses","volume":"24","author":"Su","year":"2016","journal-title":"Trends Microbiol"},{"key":"R3-20240828","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China:A retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"R4-20240828","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cca.2020.03.022","article-title":"Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections:A meta-analysis","volume":"506","author":"Lippi","year":"2020","journal-title":"Clin Chim Acta"},{"key":"R5-20240828","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"R6-20240828","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/JCMA.0000000000000463","article-title":"Clinical manifestation and disease progression in COVID-19 infection","volume":"84","author":"Tsai","year":"2021","journal-title":"J Chin Med Assoc"},{"key":"R7-20240828","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","article-title":"COVID-19 and thrombotic or thromboembolic disease:Implications for prevention, antithrombotic therapy, and follow-up:JACC state-of-the-art review","volume":"75","author":"Bikdeli","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R8-20240828","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, Function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"R9-20240828","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.cardfail.2020.04.009","article-title":"Elevated troponin in patients with coronavirus disease 2019:Possible mechanisms","volume":"26","author":"Tersalvi","year":"2020","journal-title":"J Card Fail"},{"key":"R10-20240828","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"R11-20240828","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s13054-020-03062-7","article-title":"The vascular endothelium:The cornerstone of organ dysfunction in severe SARS-CoV-2 infection","volume":"24","author":"Pons","year":"2020","journal-title":"Crit Care"},{"key":"R12-20240828","doi-asserted-by":"crossref","first-page":"118102","DOI":"10.1016\/j.lfs.2020.118102","article-title":"Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19:Lessons from SARS and MERS, and potential therapeutic interventions","volume":"257","author":"Jafarzadeh","year":"2020","journal-title":"Life Sci"},{"key":"R13-20240828","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.3389\/fimmu.2020.01472","article-title":"Intoxication with endogenous angiotensin II:A COVID-19 hypothesis","volume":"11","author":"Sfera","year":"2020","journal-title":"Front Immunol"},{"key":"R14-20240828","doi-asserted-by":"crossref","first-page":"114225","DOI":"10.1016\/j.bcp.2020.114225","article-title":"Role of proteolytic enzymes in the COVID-19 infection and promising therapeutic approaches","volume":"182","author":"Gioia","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"R15-20240828","doi-asserted-by":"crossref","first-page":"e202000786","DOI":"10.26508\/lsa.202000786","article-title":"TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells","volume":"3","author":"Bestle","year":"2020","journal-title":"Life Sci Alliance"},{"key":"R16-20240828","doi-asserted-by":"crossref","first-page":"117905","DOI":"10.1016\/j.lfs.2020.117905","article-title":"Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to macrophage activation syndrome:Therapeutic implications","volume":"256","author":"Banu","year":"2020","journal-title":"Life Sci"},{"key":"R17-20240828","doi-asserted-by":"crossref","first-page":"8887","DOI":"10.1128\/JVI.00415-08","article-title":"Cathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide","volume":"82","author":"Bosch","year":"2008","journal-title":"J Virol"},{"key":"R18-20240828","doi-asserted-by":"crossref","first-page":"49","DOI":"10.11613\/BM.2012.006","article-title":"Inflammation and haemostasis","volume":"22","author":"Margetic","year":"2012","journal-title":"Biochem Med (Zagreb)"},{"key":"R19-20240828","first-page":"55917","article-title":"Investigating von willebrand factor pathophysiology using a flow chamber model of von willebrand factor-platelet string formation","volume":"126","author":"Michels","year":"2017","journal-title":"J Vis Exp"},{"key":"R20-20240828","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1089\/ars.2009.2875","article-title":"Oxidative stress and vascular smooth muscle cell growth:A mechanistic linkage by cyclophilin A","volume":"12","author":"Satoh","year":"2010","journal-title":"Antioxid Redox Signal"},{"key":"R21-20240828","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","article-title":"Fibrotic disease and the T(H)1\/T(H)2 paradigm","volume":"4","author":"Wynn","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"R22-20240828","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1001\/jamainternmed.2020.3596","article-title":"Factors associated with death in critically ill patients with coronavirus disease 2019 in the US","volume":"180","author":"Gupta","year":"2020","journal-title":"JAMA Intern Med"},{"key":"R23-20240828","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/jama.2020.4326","article-title":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State","volume":"323","author":"Arentz","year":"2020","journal-title":"JAMA"},{"key":"R24-20240828","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.cardfail.2020.04.013","article-title":"Joint HFSA\/ACC\/AHA statement addresses concerns re:Using RAAS antagonists in COVID-19","volume":"26","author":"Bozkurt","year":"2020","journal-title":"J Card Fail"},{"key":"R25-20240828","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat Med"},{"key":"R26-20240828","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jchf.2020.04.001","article-title":"End-stage heart failure with COVID-19:Strong evidence of myocardial injury by 2019-nCoV","volume":"8","author":"Dong","year":"2020","journal-title":"JACC Heart Fail"},{"key":"R27-20240828","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/MAT.0000000000001173","article-title":"Initial ELSO guidance document:ECMO for COVID-19 patients with severe cardiopulmonary failure","volume":"66","author":"Bartlett","year":"2020","journal-title":"ASAIO J"},{"key":"R28-20240828","doi-asserted-by":"crossref","first-page":"S853","DOI":"10.21037\/jtd.2018.10.37","article-title":"Initial experience with telemonitoring in left ventricular assist device patients","volume":"11","author":"Hohmann","year":"2019","journal-title":"J Thorac Dis"},{"key":"R29-20240828","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/CIRCULATIONAHA.112.093245","article-title":"The assessment of endothelial function:From research into clinical practice","volume":"126","author":"Flammer","year":"2012","journal-title":"Circulation"},{"key":"R30-20240828","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41569-020-0360-5","article-title":"COVID-19 and the cardiovascular system","volume":"17","author":"Zheng","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"R31-20240828","doi-asserted-by":"crossref","first-page":"9110","DOI":"10.1038\/s41598-017-09536-z","article-title":"Altered lipid metabolism in recovered SARS patients twelve years after infection","volume":"7","author":"Wu","year":"2017","journal-title":"Sci Rep"},{"key":"R32-20240828","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/01.ATV.0000051384.43104.FC","article-title":"Endothelial dysfunction:A marker of atherosclerotic risk","volume":"23","author":"Bonetti","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R33-20240828","doi-asserted-by":"crossref","first-page":"10725","DOI":"10.3390\/ijms231810725","article-title":"The perspective of vitamin D on suPAR-related AKI in COVID-19","volume":"23","author":"Liao","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R34-20240828","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/jth.14820","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Arachchillage","year":"2020","journal-title":"J Thromb Haemost"},{"key":"R35-20240828","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/jama.290.3.374","article-title":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome","volume":"290","author":"Lew","year":"2003","journal-title":"JAMA"},{"key":"R36-20240828","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1055\/s-0040-1709650","article-title":"D-dimer is associated with severity of coronavirus disease 2019:A pooled analysis","volume":"120","author":"Lippi","year":"2020","journal-title":"Thromb Haemost"},{"key":"R37-20240828","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost"},{"key":"R38-20240828","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2141.2009.07600.x","article-title":"Guidelines for the diagnosis and management of disseminated intravascular coagulation. British committee for standards in haematology","volume":"145","author":"Levi","year":"2009","journal-title":"Br J Haematol"},{"key":"R39-20240828","doi-asserted-by":"crossref","first-page":"e009042","DOI":"10.1161\/JAHA.118.009042","article-title":"Early use of echocardiography in patients with acute pulmonary embolism:Findings from the RIETE registry","volume":"7","author":"Bikdeli","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"R40-20240828","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1161\/CIRCULATIONAHA.120.047096","article-title":"Challenges in heart transplantation in the era of COVID-19","volume":"141","author":"DeFilippis","year":"2020","journal-title":"Circulation"},{"key":"R41-20240828","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/cbic.202000047","article-title":"Learning from the past:Possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV","volume":"21","author":"Morse","year":"2020","journal-title":"Chembiochem"},{"key":"R42-20240828","doi-asserted-by":"crossref","first-page":"101647","DOI":"10.1016\/j.tmaid.2020.101647","article-title":"Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19:An evaluation of the evidence","volume":"35","author":"Cao","year":"2020","journal-title":"Travel Med Infect Dis"},{"key":"R43-20240828","doi-asserted-by":"crossref","first-page":"690726","DOI":"10.3389\/fphar.2022.690726","article-title":"Efficacy and outcome of remdesivir and tocilizumab combination against dexamethasone for the treatment of severe COVID-19:A randomized controlled trial","volume":"13","author":"Mohiuddin","year":"2022","journal-title":"Front Pharmacol"},{"key":"R44-20240828","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa2031994","article-title":"Baricitinib plus remdesivir for hospitalized adults with COVID-19","volume":"384","author":"Kalil","year":"2021","journal-title":"N Engl J Med"},{"key":"R45-20240828","doi-asserted-by":"crossref","first-page":"e0273340","DOI":"10.1371\/journal.pone.0273340","article-title":"Tocilizumab, netakimab, and baricitinib in patients with mild-to-moderate COVID-19:An observational study","volume":"17","author":"Bryushkova","year":"2022","journal-title":"PLoS One"},{"key":"R46-20240828","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1743-422X-2-69","article-title":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread","volume":"2","author":"Vincent","year":"2005","journal-title":"Virol J"},{"key":"R47-20240828","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s10654-022-00891-4","article-title":"Systematic review and meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19","volume":"37","author":"Garc\u00eda-Alb\u00e9niz","year":"2022","journal-title":"Eur J Epidemiol"},{"key":"R48-20240828","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0140-6736(20)30361-5","article-title":"On the use of corticosteroids for 2019-nCoV pneumonia","volume":"395","author":"Shang","year":"2020","journal-title":"Lancet"},{"key":"R49-20240828","first-page":"CD014963","article-title":"Systemic corticosteroids for the treatment of COVID-19:Equity-related analyses and update on evidence","volume":"11","author":"Wagner","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"R50-20240828","doi-asserted-by":"crossref","first-page":"807981","DOI":"10.3389\/fmed.2022.807981","article-title":"Methylprednisolone pulses in hospitalized COVID-19 patients without respiratory failure:A randomized controlled trial","volume":"9","author":"Les","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"R51-20240828","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"R52-20240828","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2174\/1573402118666220407093332","article-title":"ACEi\/ARB and deaths of COVID-19 patients","volume":"18","author":"Azad","year":"2022","journal-title":"Curr Hypertens Rev"},{"key":"R53-20240828","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1111\/jocs.14649","article-title":"ACEi and ARB with COVID-19","volume":"35","author":"Khashkhusha","year":"2020","journal-title":"J Card Surg"},{"key":"R54-20240828","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12872-022-02626-5","article-title":"Reconsidering treatment guidelines for acute myocardial infarction during the COVID-19 pandemic","volume":"22","author":"Gao","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"R55-20240828","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2215\/CJN.13241021","article-title":"Treatment decision making for older kidney patients during COVID-19","volume":"17","author":"Porteny","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"R56-20240828","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/eurheartj\/ehac031","article-title":"Long COVID:Post-acute sequelae of COVID-19 with a cardiovascular focus","volume":"43","author":"Raman","year":"2022","journal-title":"Eur Heart J"},{"key":"R57-20240828","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID:Major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat Rev Microbiol"}],"container-title":["Tzu Chi Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/tcmj.tcmj_219_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:12:25Z","timestamp":1787760745000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/tcmj.tcmj_219_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,13]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/tcmj.tcmj_219_22","relation":{},"ISSN":["1016-3190","2223-8956"],"issn-type":[{"value":"1016-3190","type":"print"},{"value":"2223-8956","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,13]]},"assertion":[{"value":"2022-08-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}